In vivo experiments further confirmed that silencing USP13 led to a significant reduction in tumor size (Supplementary Fig. S3J), accompanied by an increase in both CD8 + T cell infiltration and the expression levels of GZMB and IFN-γ within the tumor tissue (Supplementary Fig. S3K). The gene discussed is CD8A; the disease is neoplasm.